Corporate Headquarters

                  Abcam plc
                  Discovery Drive
                  Cambridge Biomedical Campus
                  CB2 0AX
                  F: +44 (0)1223 215 215

                  Nominated Advisors and Corporate Broker

                  J.P. Morgan Cazenove
                  25 Bank Street
                  Canary Wharf
                  London E14 5JP

                  Public Relations Advisors

                  FTI Consulting
                  200 Aldersgate
                  Aldersgate Street
                  London EC1A 4HD
                  F: +44 (0)20 3727 1007

                  Joint Corporate Broker

                  Numis Securities Limited
                  The London Stock Exchange Building,
                  10 Paternoster Square, London,
                  EC4M 7LT

                  Note on Unsolicited phone calls

                  We have been made aware of instances where our shareholders have been called regarding their shareholding by persons offering to purchase their shares. This is what is known as a ‘boiler room scam’. Shareholders are advised to be very wary of any unsolicited advice, offers to buy shares at a discount or offers of free company reports. If you receive such a call, you are advised not to get into a conversation, note the name of the person and firm contacting you and then end the call.

                  Worried about shareholder fraud? Click here for advice from the Financial Conduct Authority

                  About Abcam

                  Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

                  Read more +

                  Abcam Products

                  As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

                  Read more +

                  Investor Information

                  Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

                  Read more +

                  Abcam News

                  We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

                  Read more +